The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan
- PMID: 15740411
- PMCID: PMC544553
- DOI: 10.1371/journal.pmed.0020025
The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan
Abstract
The development of an HIV vaccine remains one of the most difficult challenges confronting biomedical research today. A new international collaboration shares its plan to address the challenge
Conflict of interest statement
Figures
Comment in
-
A shot in the arm for AIDS vaccine research.PLoS Med. 2005 Feb;2(2):e36. doi: 10.1371/journal.pmed.0020036. Epub 2005 Jan 18. PLoS Med. 2005. PMID: 15740412 Free PMC article.
-
Developing an HIV vaccine: the role of efficacy studies in nonhuman primates.PLoS Med. 2005 Apr;2(4):e119. doi: 10.1371/journal.pmed.0020119. Epub 2005 Apr 26. PLoS Med. 2005. PMID: 15839746 Free PMC article. No abstract available.
References
-
- Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, et al. The need for a global HIV/AIDS vaccine enterprise. Science. 2003;300:2036–2039. - PubMed
-
- Fauci AS. HIV and AIDS: 20 years of science. Nat Med. 2003;9:839–843. - PubMed
-
- Desrosiers RC. Prospects for an AIDS vaccine. Nat Med. 2004;10:221–223. - PubMed
-
- Klausner RD, Fauci AS, Corey L, Nabel GJ, Gayle H, et al. The challenges of an HIV vaccine enterprise: Response. Science. 2004;303:1293. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
